DAM
CABA icon

DLD Asset Management’s Cabaletta Bio CABA Stock Holding History

DLD Asset Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-246,500
Closed -$261K – 207
2022
Q2 		$261K Buy
+246,500
New +$349K 0.02% 200

Other funds holding CABA

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DLD Asset Management's CABA Position: Q3 2022 in Review

DLD Asset Management sold out of Cabaletta Bio (CABA) in Q3 2022, closing a stake of 246,500 shares — an estimated $261K sold.

DLD Asset Management first reported a position in CABA in Q2 2022 and held it in 1 quarter. The position peaked at $261K in Q2 2022. 54 funds tracked by Wall St. Rank hold CABA as of Q3 2022.

  • DLD Asset Management reported no remaining Cabaletta Bio position as of Q3 2022 after selling out during the quarter.
  • DLD Asset Management sold 246,500 Cabaletta Bio shares in Q3 2022, an estimated $261K.
  • DLD Asset Management first reported a position in Cabaletta Bio in Q2 2022 and held it in 1 quarter.
  • DLD Asset Management's Cabaletta Bio position peaked at $261K in Q2 2022.
  • 54 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2022.

Based on DLD Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.